Participation Support Strategies in Rare Disease Trials

This white paper outlines the critical success factors for sponsors conducting clinical trials for rare diseases. It discusses the unique challenges faced in these trials due to low disease prevalence and limited qualified investigators, which can present significant risks to clinical development programs. The research identifies various pressures that participants may encounter, including financial, physical, logistical, and psychological burdens. It emphasizes the need for sponsors to understand these pressures and develop effective participation support strategies to enhance trial efficiency. The paper details a research initiative conducted to amplify the voices of rare disease communities and gather insights into their participation support needs. It presents findings that indicate current support services often fall short, suggesting the necessity for personalized and comprehensive assistance. The document provides actionable recommendations for sponsors to foster engagement with patient communities, integrate support strategies into risk management plans, and develop realistic budget scenarios to mitigate participation burdens. These steps are essential for improving trial participation and outcomes.